ReShape Lifesciences Inc. (RSLS) Tops Q1 EPS by 1898c
Tweet
Share
E-mailGet Alerts RSLS Hot Sheet
Join SI Premium – FREE
ReShape Lifesciences Inc. (NASDAQ: RSLS) reported Q1 EPS of $18.98. Revenue for the quarter came in at $1.1 million.
For earnings history and earnings-related data on ReShape Lifesciences Inc. (RSLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Full Circle Lithium closes $5.14M private placement
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
